Sep 27 2024
A new double-blind, placebo-controlled trial published in Kidney Medicine found that a cannabis-containing cream significantly reduced itching in patients with chronic kidney disease (CKD) undergoing hemodialysis. The study, conducted by researchers from Thammasat University in Thailand, involved 60 participants, all experiencing moderate to severe CKD-associated pruritus. The participants were divided into two groups: one received …
Sep 26 2024
A study published in the peer reviewed journal Cannabis and Cannabinoid Research and available online through the U.S. National Library of Medicine explores the effects of Cannabistilbene I (a compound found in cannabis) on Angiotensin II (Ang II)-induced cardiac hypertrophy. The research, conducted by a team at the University of Alberta, examined how Cannabistilbene I …
Sep 25 2024
Researchers at Johns Hopkins University School of Medicine have conducted a longitudinal study exploring how psilocybin experiences impact people’s beliefs about mind perception and their spiritual or metaphysical views. Published recently in the Journal of Psychoactive Drugs, the study involved 657 participants who planned to have a psilocybin experience outside a clinical setting. Participants were …
Sep 21 2024
A new study published in the Journal of Chromatography B highlights a rigorous approach to identifying and quantifying cannabis terpenes and terpenoids, critical secondary metabolites that are believed to play a role in the entourage effect when combined with cannabinoids. The study addresses a key issue in the accurate quantification of terpenes, which are responsible …
Sep 18 2024
According to a study published recently in JAMA Network Open, there was no significant impact on brain activation in individuals using medical marijuana over the course of a year. Titled Year-Long Cannabis Use for Medical Symptoms and Brain Activation During Cognitive Processes and conducted by researchers from Universitas Mercatorum, University of Foggia, University of Bari, and …
Sep 17 2024
A new study of hundreds of people using medical marijuana reported “rapid and significant improvements” in health-related quality of life over the first three months, according to new research led by Philadelphia College of Osteopathic Medicine (PCOM). The study, published in the Journal of Cannabis Research, followed nearly 400 adults who were new to using medical marijuana …
Sep 17 2024
A new case report, published in the journal Clinical Case Reports and available online through the National Institutes of Health, suggests that psilocybin may offer a promising treatment option for patients with Complex Regional Pain Syndrome (CRPS). The study was conducted by researchers from Johns Hopkins University School of Medicine, the University of California San …
Sep 14 2024
According to a new study published in the journal Pain Management Nursing, hemp seed oil may help alleviate the pain associated with knee osteoarthritis (OA), a widespread and crippling condition, especially for the elderly. The randomized, double-blind controlled trial aimed to determine if topical hemp seed oil could provide relief comparable to standard treatments like …
Sep 13 2024
A recent study published in the Journal of Cellular and Molecular Medicine has revealed that cannabidiol (CBD) may have antiviral properties against the SARS-CoV-2 virus, which causes COVID-19. “The aim of this study was to determine the antiviral activity of cannabidiol (CBD) against SARS-CoV-2 infection”, states the study’s abstract. “CBD is the second most studied …
Sep 12 2024
A new case report published in the Journal of Palliative Medicine reveals the potential of psilocybin-assisted therapy (PAT) to provide relief for patients with terminal brain cancer facing existential distress. Conducted at McGill University, the study follows a patient with stage 4 astrocytoma who, after conventional treatments failed, found significant psychological relief through PAT—without any …
